Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Division of Psychology and Mental Health, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK; 2 NICM Health Research In- stitute, Western Sydney University, Westmead, NSW, Australia; 3 Department of Neurosciences, University of Padua, Padua, Italy; 4 MRC Integrative Epidemi- ology Unit, University of Bristol, Bristol, UK; 5 KU Leuven Department of Rehabilitation Sciences, Leuven, Belgium; 6 University Psychiatric Centre KU Leu- ven, Kortenberg, Belgium; 7 Department of Sports Methods and Techniques, Federal University of Santa Maria, Santa Maria, Brazil; 8 UKCRC Centre for Diet and Activity Research (CEDAR) and MRC Epidemiology Unit, University of Cambridge, Cambridge, UK; 9 Mental Health and Addictions Research Group, Department of Health Sciences, University of York, York, UK; 10Department of Psychiatry, Beth Israel Deaconess Medical Canter, Harvard Medical School, Boston, MA, USA; 11School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; 12Department of Behavioural Science and Health, University College London, London, UK; 13Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK; 14Food & Mood Centre, IMPACT – Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Aus- tralia; 15Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy; 16Department of Exercise Sciences, University of Toronto, Toronto, ON, Canada; 17South London and Maudsley NHS Foundation Trust, London, UK; 18Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK; 19Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia; 20School of Medicine, University of Queensland, Brisbane, QLD, Australia; 21Department of Psychiatry, University of Melbourne, The Melbourne Clinic, Melbourne, VIC, Australia; 22Centre for Addiction & Mental Health, Toronto, ON, Canada; 23Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Список исп. литературыСкрыть список 1. Kessler RC, Demler O, Frank RG et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352:2515-23. 2. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry 2016; 3:171-8. 3. Patel V, Saxena S, Lund C et al. The Lancet Commission on global mental health and sustainable development. Lancet 2018; 392: 1553-98. 4. Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry 2018; 17:49-60. 5. Singla DR, Raviola G, Patel V. Scaling up psychological treatments for common mental disorders: a call to action. World Psychiatry 2018; 17:226-7. doi: 10.1002/wps.20773 6. Royal College of Psychiatrists. No health without public mental health: the case for action. https://www.rcpsych.ac.uk/pdf/ PS04_2010.pdf. 7. Patalay P, Gage SH. Changes in millennial adolescent mental health and health-related behaviours over 10 years: a population cohort comparison study. Int J Epidemiol 2019;48:1650-64. 8. Lianov L, Johnson M. Physician competencies for prescribing lifestyle medicine. JAMA 2010;304:202-3. 9. Firth J, Siddiqi N, Koyanagi A et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 2019;6:675-712. 10. Stubbs B, Koyanagi A, Hallgren M et al. Physical activity and anxiety: a perspective from the World Health Survey. J Affect Disord 2017;208:545-52. 11. Stubbs B, Vancampfort D, Firth J et al. Association between depression and smoking: a global perspective from 48 low-and middle-income countries. J Psychiatr Res 2018;103:142-9. 12. Vancampfort D, Van Damme T, Stubbs B et al. Sedentary behavior and anxiety-induced sleep disturbance among 181,093 adolescents from 67 countries: a global perspective. Sleep Med 2019;58:19-26. 13. Piercy KL, Troiano RP, Ballard RM et al. The physical activity guidelines for Americans. JAMA 2018;320:2020-8. 14. Department of Health and Social Care. UK Chief Medical Officers’ Physical Activity Guidelines. www.gov.uk/government/news/new-physical-activityguidelines. 15. Tremblay MS, Carson V, Chaput J-P et al. Canadian 24-hour movement guidelines for children and youth: an integration of physical activity, sedentary behaviour, and sleep. Appl Physiol Nutr Metab 2016;41:S311-27. 16. Australian Department of Health. Australia’s Physical Activity and Sedentary Behaviour Guidelines and the Australian 24-Hour Movement Guidelines. www1.health.gov.au/internet/main/publishing.nsf/ Content/health-pubhlth-strateg-phys-act-guidelines. 17. Stubbs B, Vancampfort D, Hallgren M et al. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 2018;54:124-44 . 18. Malhi GS, Bassett D, Boyce P et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49:1087-206. 19. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for sys tematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. 20. Firth J, Teasdale S, Allot K et al. The efficacy and safety of nutrient supple ments in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019;18:308-24. 21. Webb AR. Who, what, where and when – influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25. 22. Friso S, Choi S-W, Girelli D et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002;99:5606-11. 23. Murray RM, Quigley H, Quattrone D et al. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry 2016;15:195-204. 24. Smith GD, Ebrahim S. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1076-9. 25. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42. 26. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014;23:R89-98. 27. Biddle SJ, Ciaccioni S, Thomas G et al. Physical activity and mental health in children and adolescents: an updated review of reviews and an analysis of causality. Psychol Sport Exerc 2019;42:146-55. 28. Shafiei F, Salari-Moghaddam A, Larijani B et al. Adherence to the Mediterranean diet and risk of depression: a systematic review and updated metaanalysis of observational studies. Nutr Rev 2019;77:230-9. 29. Schuch FB, Vancampfort D, Firth J et al. Physical activity and incident depression: a meta-analysis of prospective cohort studies. Am J Psychiatry 2018;175:631-48. 30. Wang X, Li Y, Fan H. The associations between screen time-based sedentary behavior and depression: a systematic review and meta-analysis. BMC Public Health 2019;19:1524. 31. Liu M, Wu L, Yao S. Dose-response association of screen time-based sedentary behaviour in children and adolescents and depression: a meta-analysis of observational studies. Br J Sports Med 2016;50:1252-58. 32. Zhai L, Zhang Y, Zhang D. Sedentary behaviour and the risk of depression: a meta-analysis. Br J Sports Med 2015;49:705-9. 33. Choi KW, Chen C-Y, Stein MB et al. Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study. JAMA Psychiatry 2019;76:399-408. 34. Choi KW, Stein MB, Nishimi K et al. A two-stage approach to identifying and validating modifiable factors for the prevention of depression. bioRxiv 2019:759753. 35. Wray NR, Ripke S, Mattheisen M et al. Genome-wide association analyses identify 44 risk variance and refine the genetic architecture of major depression. Nat Genet 2018;50:668-81. 36. Schuch FB, Stubbs B, Meyer J et al. Physical activity protects from incident anxiety: a meta-analysis of prospective cohort studies. Depress Anxiety 2019;36:846-58. 37. McDowell CP, Dishman RK, Gordon BR et al. Physical activity and anxiety: a systematic review and meta-analysis of prospective cohort studies. Am J Prev Med 2019;57:545-56. 38. Brokmeier L, Firth J, Vancampfort D et al. Does physical activity reduce the risk of psychosis? A systematic review and meta-analysis of prospective studies. Psychiatry Res 2020;284:112675. 39. Sun H, Gao X, Que X et al. The causal relationships of device-measured physical activity with bipolar disorder and schizophrenia in adults: a 2-sample Mendelian randomization study. J Affect Disord 2019;263:598-604. 40. Stahl EA, Breen G, Forstner AJ et al. Genome-wide association study identi fies 30 loci associated with bipolar disorder. Nat Genet 2019;51:793-803. 41. Ruderfer DM, Ripke S, McQuillin A et al. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 2018;173:1705-15. 42. Luger TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav 2014;39:1418-29. 43. Chaiton MO, Cohen JE, O’Loughlin J et al. A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health 2009;9:356. 44. Han C, Liu Y, Gong X et al. Relationship between secondhand smoke exposure and depressive symptoms: a systematic review and dose-response meta-analysis. Int J Environ Res Public Health 2019;16:8. 45. Chen HL, Cai JY, Zha ML et al. Prenatal smoking and postpartum depression: a meta-analysis. J Psychosom Obstet Gynecol 2019;40:97-105. 46. Bjorngaard JH, Gunnell D, Elvestad MB et al. The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Psychol Med 2013;43:711-9. 47. Wium-Andersen MK, Orsted DD, Nordestgaard BG. Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression. Int J Epidemiol 2015;44:566-77. 48. Lewis SJ, Araya R, Smith GD et al. Smoking is associated with, but does not cause, depressed mood in pregnancy – a Mendelian randomization study. PLoS One 2011;6:e21689. 49. Taylor AE, Fluharty ME, Bjorngaard JH et al. Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium. BMJ Open 2014;4:e006141. 50. Ware JJ, van den Bree MB, Munafò МР. Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res 2011;13:1167-75. 51. Wootton RE, Richmond RC, Stuijfzand BG et al. Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol Med (in press). 52. Hunter A, Murray R, Asher L et al. The effects of tobacco smoking, and prenatal tobacco smoke exposure, on risk of schizophrenia: a systematic review and meta-analysis. Nicotine Tob Res 2020;22: 3-10. 53. Gurillo P, Jauhar S, Murray RM et al. Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry 2015;2:718-25. 54. Sankaranarayanan A, Mancuso S, Wilding H et al. Smoking, suicidality and psychosis: a systematic meta-analysis. PLoS One 2015;10:e0138147. 55. Gage SH, Jones HJ, Taylor AE et al. Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization. Sci Rep 2017;7:40653. 56. Vermeulen JM, Wootton RE, Treur JL et al. Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study. Br J Psychiatry (in press). 57. Huang L, Wang Y, Zhang L et al. Maternal smoking and attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Pediatrics 2018;141: e20172465. 58. Treur J, Demontis D, Davey Smith G et al. Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization. Addict Biol 2020:e12849. 59. Demontis D, Walters RK, Martin J et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet 2019;51:63-75. 60. Molendijk M, Molero P, Ortuno Sanchez-Pedreno F et al. Diet quality and depression risk: a systematic review and dose-response meta-analysis of prospective studies. J Affect Disord 2018;226:346-54. 61. Lassale C, Batty GD, Baghdadli A et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry 2019;24:965-86. 62. Nicolaou M, Colpo M, Vermeulen E et al. Association of a priori dietary patterns with depressive symptoms: a harmonised meta-analysis of observational studies. Psychol Med (in press). 63. Tolkien K, Bradburn S, Murgatroyd C. An anti-inflammatory diet as a potential intervention for depressive disorders: a systematic review and meta-analysis. Clin Nutr 2019;38:2045-52. 64. Saghafian F, Malmir H, Saneei P et al. Fruit and vegetable consumption and risk of depression: accumulative evidence from an updated systematic review and meta-analysis of epidemiological studies. Br J Nutr 2018;119:1087-101. 65. Grosso G, Micek A, Marventano S et al. Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies. J Affect Disord 2016;205:269-81. 66. Li Z, Li B, Song X et al. Dietary zinc and iron intake and risk of depression: a meta-analysis. Psychiatry Res 2017;251:41-7. 67. Zhang Y, Yang Y, Xie MS et al. Is meat consumption associated with depression? A meta-analysis of observational studies. BMC Psychiatry 2017;17:409. 68. Hu D, Cheng L, Jiang W. Sugar-sweetened beverages consumption and the risk of depression: a meta-analysis of observational studies. J Affect Disord 2019;245:348-55. 69. Salari-Moghaddam A, Saneei P, Larijani B et al. Glycemic index, glycemic load, and depression: a systematic review and meta-analysis. Eur J Clin Nutr 2019;73:356-65. 70. Bao YP, Han Y, Ma J et al. Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review. Neurosci Biobehav 2017;75:257-73. 71. Wang X, Cheng S, Xu H. Systematic review and meta-analysis of the relationship between sleep disorders and suicidal behaviour in patients with depres sion. BMC Psychiatry 2019;19:303. 72. Li L, Wu C, Gan Y et al. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry 2016;16:375. 73. Hertenstein E, Feige B, Gmeiner T et al. Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev 2019;43:96-105. 74. Zhai L, Zhang H, Zhang D. Sleep duration and depression among adults: a meta-analysis of prospective studies. Depress Anxiety 2015;32:664-70. 75. Lee S-H, Kim H-B, Lee K-W. Association between sleep duration and attention-deficit hyperactivity disorder: a systematic review and meta-analysis of observational studies. J Affect Disord 2019;256: 62-9. 76. Gao X, Meng LX, Ma KL et al. The bidirectional causal relationships of insomnia with five major psychiatric disorders: a Mendelian randomization study. Eur Psychiatry 2019;60:79-85. 77. Ashdown-Franks G, Firth J, Carney R et al. Exercise as medicine for mental and substance use disorders: a meta-review of the benefits for neuropsychiatric and cognitive outcomes. Sports Med 2020;50:151-70. 78. Pelsser LM, Frankena K, Toorman J et al. Diet and ADHD, reviewing the evidence: a systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD. PLoS One 2017;12:e0169277. 79. Gee B, Orchard F, Clarke E et al. The effect of non-pharmacological sleep interventions on depression symptoms: a meta-analysis of randomised controlled trials. Sleep Med Rev 2019;43:118-28. 80. Povitz M, Bolo CE, Heitman SJ et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med 2014;11:e1001762. 81. Gebara MA, Siripong N, DiNapoli EA et al. Effect of insomnia treatments on depression: a systematic review and meta-analysis. Depress Anxiety 2018;35:717-31. 82. Kessler RC, Angermeyer M, Anthony JC et al. Lifetime prevalence and age of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 2007;6:168-76. 83. Hoare E, Thorisdóttir IE, Kristjansson AL et al. Lessons from Iceland: developing scalable and sustainable community approaches for the prevention of mental disorders in young Australians. Mental Health & Prevention 2019;15:200166. 84. Malakellis M, Hoare E, Sanigorski A et al. School-based systems change for obesity prevention in adolescents: outcomes of the Australian Capital Territory ‘It’s Your Move!’. Aust N Z J Public Health 2017;41:490-6. 85. Kandola A, Ashdown-Franks G, Stubbs B et al. The association between cardiorespiratory fitness and the incidence of common mental health disorders: a systematic review and meta-analysis. J Affect Disord 2019;257:748-57. 86. Schuch FB, Vancampfort D, Sui X et al. Are lower levels of cardiorespiratory fitness associated with incident depression? A systematic review of prospective cohort studies. Prev Med 2016;93:159-65. 87. Tacchi MJ, Heggelund J, Scott J. Predictive validity of objective measures of physical fitness for the new onset of mental disorders in adolescents and young adults. Early Interv Psychiatry 2019;13:1310-8. 88. Ortega FB, Silventoinen K, Tynelius P et al. Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ 2012;345:e7279. 89. Gordon BR, McDowell CP, Lyons M et al. Associations between grip strength and generalized anxiety disorder in older adults: results from the Irish longitudinal study on ageing. J Affect Disord 2019;255:136-41. 90. Bennie JA, Teychenne MJ, De Cocker K et al. Associations between aerobic and muscle-strengthening exercise with depressive symptom severity among 17,839 US adults. Prev Med 2019;121:121-7. 91. Gordon BR, McDowell CP, Hallgren M et al. Association of efficacy of resistance exercise training with depressive symptoms meta-analysis and meta-regression: analysis of randomized clinical trials. JAMA Psychiatry 2018;75:566-76. 92. Gordon BR, McDowell CP, Lyons M et al. The effects of resistance exercise training on anxiety: a meta-analysis and meta-regression analysis of ran domized controlled trials. Sports Med 2017;47:2521-32. 93. Nebiker L, Lichtenstein E, Minghetti A et al. Moderating effects of exercise duration and intensity in neuromuscular vs. endurance exercise interven tions for the treatment of depression: a meta-analytical review. Front Psychiatry 2018;9:305. 94. Ye Y-Y, Chen N-K, Chen J et al. Internet-based cognitive-behavioural therapy for insomnia (ICBT-i): a meta-analysis of randomised controlled trials. BMJ Open 2016;6:e010707. 95. Freeman D, Sheaves B, Goodwin GM et al. The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. Lancet Psychiatry 2017;4:749-58. 96. Krystal AD, Prather AA, Ashbrook LH. The assessment and management of insomnia: an update. World Psychiatry 2019;18:337-52. 97. Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health 2017;38:165-85. 98. Peckham E, Brabyn S, Cook L et al. Smoking cessation in severe mental ill health: What works? An updated systematic review and meta-analysis. BMC Psychiatry 2017;17:252. 99. Taylor G, McNeill A, Girling A et al. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014;348:g1151. 100. Gilbody S, Peckham E, Bailey D et al. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry 2019;6:379-90. 101. Bot M, Brouwer IA, Roca M et al. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD randomized clinical trial. JAMA 2019;321:858-68. 102. Francis HM, Stevenson RJ, Chambers JR et al. A brief diet intervention can reduce symptoms of depression in young adults – A randomised controlled trial. PLoS One 2019;14:e0222768. 103. Jacka FN, O’Neil A, Opie R et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med 2017;15:23. 104. Parletta N, Zarnowiecki D, Cho J et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED). Nutr Neurosci 2019;22:474-87. 105. Firth J, Stubbs B, Teasdale SB et al. Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness. World Psychiatry 2018;17:365-7. 106. Teasdale S, Firth J. Recommendations for dietetics in mental healthcare. J Hum Nutr Diet 2020;33:149-50 107. Morgan JA, Olagunju AT, Corrigan F et al. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers. J Affect Disord 2018;234:180-92. 108. O’Keefe JH, Gheewala NM, O’Keefe JO. Dietary strategies for improving postprandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008;51:249-55. 109. Kiecolt-Glaser JK, Fagundes CP, Andridge R et al. Depression, daily stressors and inflammatory responses to high-fat meals: when stress overrides healthier food choices. Mol Psychiatry 2017;22:476-82. 110. Krysta K, Krzystanek M, Bratek A et al. Sleep and inflammatory markers in different psychiatric disorders. J Neural Transm 2017;124:179-86. 111. Hamer M, Molloy GJ, de Oliveira C et al. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship? Brain Behav Immun 2009;23:413-8. 112. Yuan N, Chen Y, Xia Y et al. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry 2019;9:1-13. 113. Gleeson M, Bishop NC, Stensel DJ et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nature Rev Immunol 2011;11:607-15. 114. Kastorini C-M, Milionis HJ, Esposito K et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011;57:1299-313. 115. Chen H-Y, Cheng I-C, Pan Y-J et al. Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemo - dialysis patients. Kidney Int 2011;80:415-22. 116. Reichert V, Xue X, Bartscherer D et al. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 2009;136:212-9. 117. Dinan TG, Cryan JF. Gut microbiota: a missing link in psychiatry. World Psychiatry 2020;19:111-2. 118. Mailing LJ, Allen JM, Buford TW et al. Exercise and the gut microbiome: a review of the evidence, potential mechanisms, and implications for human health. Exerc Sport Sci Rev 2019;47:75-85. 119. Ghosh T, Rampelli S, Jeffery I. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 2020;69:1218-28. 120. Eisenstein M. The hunt for a healthy microbiome. Nature 2020;577:S6. 121. Wootton RE, Lawn RB, Millard LA et al. Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: Mendelian randomisation study. BMJ 2018;362:k3788. 122. Jebeile H, Gow ML, Baur LA et al. Association of pediatric obesity treatment, including a dietary component, with change in depression and anxiety: a systematic review and meta-analysis. JAMA Pediatrics 2019;173:e192841. 123. Salvi V, Hajek T. Brain-metabolic crossroads in severe mental disorders. Front Psychiatry 2019;10:492. 124. Firth J, Torous J, Stubbs B et al. The “online brain”: how the Internet may be changing our cognition. World Psychiatry 2019;18:119-29. 125. Linardon J, Cuijpers P, Carlbring P et al. The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials. World Psychiatry 2019;18:325-36. 126. Bucci S, Lewis S, Ainsworth J et al. Digital interventions in severe mental health problems: lessons from the Actissist development and trial. World Psychiatry 2018;17:230-1